NEWS
New Feature!!!! University Subject Rankings in 12 branches
FOR SCIENTIST REGISTRATION FOR INSTITUTIONAL BULK REGISTRATION
FOR EDIT YOUR UNIVERSITY / INSTITUTION PAGE
Some differences of the AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
List without CERN, Statistical Data etc. Only in AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
AD
Scientific Index 2024
About Us
Methodology
Compare & Choose
Contact - FAQ
login
Login
person_add
Register
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
school
University Rankings
subject
University Subject Rankings
insights
Subject Rankings
place
Country Rankings
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
local_fire_department
Country Top Lists
Alexander Drilon
Memorial Sloan Kettering Cancer Center - Indore / United States
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 4441097
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Alexander Drilon's MOST POPULAR ARTICLES
1-)
Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and ChildrenA Drilon, TW Laetsch, S Kummar, SG DuBois, UN Lassen, GD Demetri, ...New England Journal of Medicine 378 (8), 731-739, 201818692018
2-)
Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trialsRC Doebele, A Drilon, L Paz-Ares, S Siena, AT Shaw, AF Farago, ...The Lancet Oncology 21 (2), 271-282, 202010232020
3-)
NTRK fusion-positive cancers and TRK inhibitor therapyE Cocco, M Scaltriti, A DrilonNature reviews Clinical oncology 15 (12), 731-747, 201810122018
4-)
Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registryJ Mazieres, A Drilon, A Lusque, L Mhanna, AB Cortot, L Mezquita, ...Annals of Oncology 30 (8), 1321-1328, 201910782019
5-)
Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trialsDS Hong, SG DuBois, S Kummar, AF Farago, CM Albert, KS Rohrberg, ...The Lancet Oncology 21 (4), 531-540, 20208232020
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept